LEADER 01491nam  2200421 a 450 
001 9910698011603321
005 20091211120808.0
035   $a(CKB)5470000002394891
035   $a(OCoLC)311601677
035   $a(EXLCZ)995470000002394891
100   $a20090302d2007      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicare prescription drug benefit$b[electronic resource] $ereview and oversight : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, May 8, 2007
210  1$aWashington :$cU.S. G.P.O.,$d2007.
215   $aiii, 112 pages $cdigital, PDF file
225 1 $aS. hrg. ;$v110-574
300   $aTitle from title screen (viewed on Mar. 2, 2009).
300   $aPaper version available for sale by the Supt. of Docs.
320   $aIncludes bibliographical references.
517   $aMedicare prescription drug benefit 
606   $aPharmaceutical services insurance$zUnited States
606   $aDrugs$xPrices$zUnited States
606   $aPrescription pricing$zUnited States
606   $aMedicare
615  0$aPharmaceutical services insurance
615  0$aDrugs$xPrices
615  0$aPrescription pricing
615  0$aMedicare.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698011603321
996   $aMedicare prescription drug benefit$93480894
997   $aUNINA